1. Highly Selective Targeting of Pancreatic Cancer in the Liver with a Near-Infrared Anti-MUC5AC Probe in a PDOX Mouse Model: A Proof-of-Concept Study
   Michael A. Turner et al, 2023, Journal of Personalized Medicine CrossRef
2. CSTF2T facilitates pancreatic adenocarcinoma growth and metastasis by elevating H3K4Me1 methylation of CALB2 via ASH2L
   Wei Liu et al, 2023, Cancer Biology & Therapy CrossRef
3. Management of Metastatic Pancreatic Cancer—Comparison of Global Guidelines over the Last 5 Years
   Monika Pajewska et al, 2023, Cancers CrossRef
4. The bacterial metabolite, lithocholic acid, has antineoplastic effects in pancreatic adenocarcinoma
   Szandra Schwarcz et al, 2024, Cell Death Discovery CrossRef
5. Nanocarrier mediated entinostat and oxaliplatin combination therapy displayed enhanced efficacy against pancreatic cancer
   Paras Mani Giri et al, 2024, Biomedicine & Pharmacotherapy CrossRef
6. FTO Knockdown-Mediated Maturation of miR-383-5p Inhibits Malignant Advancement of Pancreatic Cancer by Targeting ITGA3
   Wei Zhang et al, 2023, Biochemical Genetics CrossRef
7. Prediction of postoperative liver metastasis in pancreatic ductal adenocarcinoma based on multiparametric magnetic resonance radiomics combined with serological markers: a cohort study of machine learning
   Zhongyu Yuan et al, 2023, Abdominal Radiology CrossRef
8. Design, Synthesis, and Antitumor Evaluation of an Opioid Growth Factor Bioconjugate Targeting Pancreatic Ductal Adenocarcinoma
   Justyna Budka et al, 2024, Pharmaceutics CrossRef
9. The impact of metastatic sites on survival Rates and predictors of extended survival in patients with metastatic pancreatic cancer
   Jonah M. Levine et al, 2024, Pancreatology CrossRef
10. Long non-coding RNAs and pancreatic cancer: A multifaceted view
    null Bin Wang et al, 2023, Biomedicine & Pharmacotherapy CrossRef
11. Landmarks in pancreatic cancer studies
    Fan Xu et al, 2022, Cancer Cell International CrossRef
12. Dissimilar survival and clinicopathological characteristics of mucinous adenocarcinoma located in pancreatic head and body/tail
    Zheng Li et al, 2023, World Journal of Gastrointestinal Surgery CrossRef
13. Clinical Study of Anti-PD-1 Immunotherapy Combined with Gemcitabine Chemotherapy in Multiline Treatment of Advanced Pancreatic Cancer
    Yanfeng Liu et al, 2022, Computational and Mathematical Methods in Medicine CrossRef
14. CD44 and RHAMM Are Microenvironmental Sensors with Dual Metastasis Promoter and Suppressor Functions
    Cornelia Tolg et al, 2024, Advanced Biology CrossRef
15. Personalized medicine and new therapeutic approach in the treatment of pancreatic cancer
    Hanieh Azari et al, 2024, Recent Advances in Nanocarriers for Pancreatic Cancer Therapy CrossRef
16. The role of histone H1.2 in pancreatic cancer metastasis and chemoresistance
    Jianyou Gu et al, 2024, Drug Resistance Updates CrossRef
17. Elastic modulus-reflected liver lesion stiffness relates to worse prognosis in pancreatic cancer patients with liver metastasis
    Shu Dong et al, 2023, World Journal of Surgical Oncology CrossRef
18. Oxidative Stress Markers Are Associated with a Poor Prognosis in Patients with Pancreatic Cancer
    Miguel A. Ortega et al, 2022, Antioxidants CrossRef
19. A powerful machine learning approach to identify interactions of differentially abundant gut microbial subsets in patients with metastatic and non-metastatic pancreatic cancer
    Annacandida Villani et al, 2024, Gut Microbes CrossRef
20. Research Progress of Neural Invasion in Pancreatic Cancer
    Mengying Zhu et al, 2024, Current Cancer Drug Targets CrossRef
21. Pevonedistat Suppresses Pancreatic Cancer Growth via Inactivation of the Neddylation Pathway
    Junfeng Xu et al, 2022, Frontiers in Oncology CrossRef
22. Unveiling the intricate causal nexus between pancreatic cancer and peripheral metabolites through a comprehensive bidirectional two-sample Mendelian randomization analysis
    Rong Sun et al, 2023, Frontiers in Molecular Biosciences CrossRef